Pat Gulhati

发表

Phase II Study of Panitumumab in RAS Wild‐Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater

Jeffrey S. Morris, Huamin Wang, R. Wolff, 2017, The oncologist.

Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.

Eun Ryoung Jang, Chi Wang, H. Weiss, 2013, Carcinogenesis.

Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer

N. Navin, R. DePinho, A. Maitra, 2022, Nature Cancer.

Therapeutics , Targets , and Chemical Biology InhibitionofFattyAcidSynthaseAttenuatesCD 44-Associated Signaling and Reduces Metastasis in Colorectal Cancer

W. Mustain, H. Weiss, Eun Y. Lee, 2012 .

InhibitionofFattyAcidSynthaseAttenuatesCD 44-Associated Signaling and Reduces Metastasis in Colorectal Cancer

W. Mustain, H. Weiss, Eun Y. Lee, 2012 .

Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.

Sara M. Johnson, B. Rampy, H. Weiss, 2010, Journal of the American College of Surgeons.

Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling.

Sara M. Johnson, B. Evers, T. Uchida, 2009, Anticancer research.

Targeted Inhibition of Mammalian Target of Rapamycin Signaling Inhibits Tumorigenesis of Colorectal Cancer

Suimin Qiu, Jing Li, Eun Y. Lee, 2009, Clinical Cancer Research.

mTOR inhibitors in cancer therapy.

B. Evers, Y. Zaytseva, Pat Gulhati, 2012, Cancer letters.

Molecular Landscape of Small Bowel Adenocarcinoma

M. Overman, Pat Gulhati, Karan Pandya, 2022, Cancers.

Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA.

S. Shirasawa, T. Sasazuki, H. Weiss, 2012, Carcinogenesis.

mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.

H. Weiss, Eun Y. Lee, B. Evers, 2011, Cancer research.

Molecular and Cellular Pathobiology mTORC 1 and mTORC 2 Regulate EMT , Motility , and Metastasis of Colorectal Cancer via RhoA and Rac 1 Signaling Pathways

H. Weiss, Eun Y. Lee, B. Evers, 2011 .

Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis

Hung Q. Doan, D. Chung, Junghee Kang, 2008, Proceedings of the National Academy of Sciences.

Characterization of Promoter Elements Regulating the Expression of the Human Neurotensin/Neuromedin N Gene*

H. Weiss, B. Evers, C. Townsend, 2010, The Journal of Biological Chemistry.

Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.

W. Mustain, H. Weiss, Eun Y. Lee, 2012, Cancer research.

An Analysis of Trends and Growth Factor Receptor Expression of GI Carcinoid Tumors

B. Evers, S. Qiu, T. Riall, 2009, Journal of Gastrointestinal Surgery.

Oncogenic Kras driven metabolic reprogramming in pancreas cancer cells utilizes cytokines from the tumor microenvironment.

R. DePinho, A. Maitra, Jun Li, 2020, Cancer discovery.

Phase II study of panitumumab in KRAS wild-type metastatic adenocarcinoma of the small bowel or ampulla of vater.

Jeffrey S. Morris, Huamin Wang, R. Wolff, 2017 .

First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma

Jeffrey E. Lee, A. Maitra, P. Bhosale, 2018, Annals of Surgical Oncology.

The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer

Wei Wang, B. Evers, Haihua Yang, 2012, Oncogene.